The Peptide Report

SLU-PP-332 Benefits: The 2026 Executive's Mitochondrial Edge - DrSeinfeld.com Operated by Ginspire Health LLC
May 13, 2026
Inside the quiet shift among Silicon Valley executives swapping their second espresso for a mitochondrial optimization protocol. A look at the ERR-pathway science driving the rise of SLU-PP-332.